JFG
BCYC

Jefferies Financial Group’s Bicycle Therapeutics BCYC Stock Holding History

Jefferies Financial Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-297,247
Closed -$2.1M – 1752
2025
Q4 		$2.1M Sell
297,247
-104,679
-26% -$772K 0.01% 784
2025
Q3 		$3.11M Sell
401,926
-59,174
-13% -$447K 0.01% 499
2025
Q2 		$3.2M Buy
461,100
+52,211
+13% +$416K 0.03% 410
2025
Q1 		$3.47M Buy
+408,889
New +$4.82M 0.03% 403
2024
Q1 		– Sell
-1,948,000
Closed -$35.2M – 1625
2023
Q4 		$35.2M Hold
1,948,000
– – 0.23% 64
2023
Q3 		$39.1M Hold
1,948,000
– – 0.35% 38
2023
Q2 		$49.7M Hold
1,948,000
– – 0.45% 36
2023
Q1 		$41.4M Buy
+1,948,000
New +$48.9M 0.34% 48

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jefferies Financial Group's BCYC Position: Q1 2026 in Review

Jefferies Financial Group sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 297,247 shares — an estimated $2.1M sold.

Jefferies Financial Group first reported a position in BCYC in Q1 2023 and held it in 8 quarters. The position peaked at $49.7M in Q2 2023. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Jefferies Financial Group reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 297,247 Bicycle Therapeutics shares in Q1 2026, an estimated $2.1M.
  • Jefferies Financial Group first reported a position in Bicycle Therapeutics in Q1 2023 and held it in 8 quarters.
  • Jefferies Financial Group's Bicycle Therapeutics position peaked at $49.7M in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.